Form 4: BioSig Technologies Interim CFO Ferdinand Groenewald Reports Acquisition and Disposal of Common Stock

Interim CFO of BioSig Technologies, Ferdinand Groenewald, reports acquiring 35,000 shares of common stock and disposing of 60,000 shares in a recent transaction.

Summary

• On April 24, 2025, Ferdinand Groenewald, Interim CFO of BioSig Technologies, acquired 35,000 shares of common stock.
• These shares were granted under the Company's 2023 Equity Incentive Plan and were fully vested as of the Date of Grant.
• The acquisition price was $0 per share, based on a closing price of $0.84 per share on the date of grant.
• Groenewald also disposed of 60,000 shares of common stock.
• Following these transactions, the amount of securities beneficially owned by Groenewald is not specified.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting stock transactions by an insider. It doesn't inherently convey positive or negative sentiment.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, which is a common practice in publicly traded companies. It provides transparency into the trading activities of key personnel.

Stakeholder Impact

• The filing provides transparency to shareholders regarding the stock transactions of a key executive.

Key Dates

Keywords

Form 4, BioSig Technologies, BSGM, Ferdinand Groenewald, Interim CFO, Beneficial Ownership, Equity Incentive Plan, Common Stock, Acquisition, Disposition